Companies · Other Health Care

Nectar Mesa McKellips, LLC

MESA · Other Health Care

Diligence memoA one-page analyst read on Nectar Mesa McKellips, LLC — recommendation, valuation, rhythm, risks.
$300K
Total raised · real
1
Rounds
Latest step-up
Top 87%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Fri Sep 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Nectar Mesa McKellips, LLC looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.63× the median modeled value of Pre-Seed Other Health Care companies in 2019–2021 (295 peers) — value vs value, same stage and era.
Dormant
  • Last raise 4.8 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Nectar Mesa McKellips, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
4.8 yr record
Peak capital year was 2021 with $300K across 1 filings.
Market position
ahead of 14% of Other Health Care peers
Capital scale is ahead of 14% of Other Health Care peers; modeled value is above 21% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2021: $300K across 1 filings.
  • Largest single filing was $300K on 2021-09-10.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Nectar Mesa McKellips, LLC is one of 5376 Other Health Care companies tracked from MESA. By capital raised it ranks in the long tail (ahead of 14% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
10
Investors (latest)
2021
Year incorporated
2021-09-10
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5M$5.0M$7.5M$10MPre-Seed · 2021-09-10 Raised $300K (real) Modeled valuation $5.1M (est)$300K$5.1MPre-Seed2021

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$300K · 2021

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$5.1M
Base estimate est.
$188K
Conservative case
$40.3M
Upside case
$1.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
4.8 yr
Elapsed time used
4.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
4.8 yr
On record since
2021
First round
1
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.1× of median
This company$300K
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 0.9× of median
This company$300K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.2× of median
This company$5.1M
Sector median$22.1M

Raised more than 14% of sector peers (real $). Modeled value above 21% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #203 of 295.

This companyCohort peer
$1.0M$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Aetas Co LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Hauppauge SC Holdings, LLC · Pre-Seed Raised $995K · modeled $30.6M (est)Gateway IV Lithotripsy, LLC · Pre-Seed Raised $988K · modeled $30.4M (est)Endoscopy Center of West Central Ohio, LLC · Pre-Seed Raised $964K · modeled $29.7M (est)Dalent LLC · Pre-Seed Raised $1.9M · modeled $29.2M (est)FK Investor LLC · Pre-Seed Raised $940K · modeled $29.0M (est)Lynx Dx, Inc. · Pre-Seed Raised $925K · modeled $28.5M (est)Center at Arrowhead, LLC · Pre-Seed Raised $918K · modeled $28.3M (est)MedTek Valencia eCoin, LLC · Pre-Seed Raised $905K · modeled $27.9M (est)Westside PetWell, LLC · Pre-Seed Raised $900K · modeled $27.7M (est)Ulster Dialysis Partners, LLC · Pre-Seed Raised $930K · modeled $27.6M (est)DoveMed, Ltd. · Pre-Seed Raised $1.5M · modeled $26.5M (est)Nectar Mesa McKellips, LLC (this company) Raised $300K · modeled $5.1M (est)Nectar Mesa McKellips, LLC
CompanyStageRaised · realValue · estvs peer med.
Aetas Co LLCPre-Seed$1.0M$30.8M3.80×
Hauppauge SC Holdings, LLCPre-Seed$995K$30.6M3.78×
Gateway IV Lithotripsy, LLCPre-Seed$988K$30.4M3.76×
Endoscopy Center of West Central Ohio, LLCPre-Seed$964K$29.7M3.67×
Dalent LLCPre-Seed$1.9M$29.2M3.61×
FK Investor LLCPre-Seed$940K$29.0M3.58×
Lynx Dx, Inc.Pre-Seed$925K$28.5M3.52×
Center at Arrowhead, LLCPre-Seed$918K$28.3M3.49×
MedTek Valencia eCoin, LLCPre-Seed$905K$27.9M3.44×
Westside PetWell, LLCPre-Seed$900K$27.7M3.42×
Ulster Dialysis Partners, LLCPre-Seed$930K$27.6M3.40×
DoveMed, Ltd.Pre-Seed$1.5M$26.5M3.28×
Nectar Mesa McKellips, LLC this companyPre-Seed$300K$5.1M0.63×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$300K2021-09-10$1.7M$5.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$300K2021-09-10
    • First recorded raise — entered as Pre-Seed.
    • 10 investors on this round.
Intelligence
Modeled next raise
$480K
Modeled next size est.range $312K$768K
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Shane Speirs1 other2021-09
Registry & provenance

Nectar Mesa McKellips, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1908012
SEC CIK
2021
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Nectar Phoenix 31st, LLCOther Health CarePre-Seed$300K$5.0Mnetwork1 shared operator · same sector · same stage
Brain Armor IncOther Health CarePre-Seed$300K$6.0Msame sector · same stage
BrainMD,LLCOther Health CarePre-Seed$300K$6.2Msame sector · same stage
CH Holdings LLCOther Health CarePre-Seed$300K$4.6Msame sector · same stage
MiracleCord, Inc.Other Health CarePre-Seed$300K$6.2Msame sector · same stage
Trifecta Holding Group Inc.Other Health CarePre-Seed$300K$5.3Msame sector · same stage
Jvhd LlcOther Health CarePre-Seed$315K$5.6Msame sector · same stage
AmplifiDx, Inc.Other Health CarePre-Seed$329K$6.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Nectar Phoenix 31st, LLCOther Health CarePre-Seed$5.0M87%
Banner Mesa Surgery Center, LLCOther Health CarePre-Seed$20.9M84%
Arcadia Communities, LLCOther Health CareSeries A$27.8M82%
Rimidi, Inc.Other Health CareSeries A$1.4M81%
Toetal Solutions, Inc.Other Health CareSeed$3.5M81%
Amplifica, Inc.Other Health CarePre-Seed$15.4M81%
SweetBio, Inc.Other Health CareSeries A$7.7M81%
Mediphore, Inc.Other Health CareSeries A$302.7M81%
Frequently asked
How much funding has Nectar Mesa McKellips, LLC raised?
Nectar Mesa McKellips, LLC has raised approximately $300K in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Nectar Mesa McKellips, LLC's estimated valuation?
Provath's modeled valuation for Nectar Mesa McKellips, LLC is approximately $5.1M (modeled range $188K–$40.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Nectar Mesa McKellips, LLC at?
Nectar Mesa McKellips, LLC's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Fri Sep 10.
What does Nectar Mesa McKellips, LLC do and where is it based?
Nectar Mesa McKellips, LLC operates in the Other Health Care sector, based in MESA.
Explore related

See where Nectar Mesa McKellips, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Nectar Mesa McKellips, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.